Vestal Point Capital’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-485,000	Closed	-$22M	–	85
2024 Q3	$22M	Sell	485,000 -240,000	-33%	-$10.9M	1.67%	19
2024 Q2	$30.4M	Buy	+725,000	New	+$30.4M	2.26%	12